GGrantIndex
Sort

326,823 grants matching clinical trial

Dana-Farber/Harvard SPORE in Breast Cancer

$2,179,546
Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2009 · CA

SPORE in Lymphoma

$2,179,484
Helen E Heslop · Baylor College Of Medicine · P50 · FY2020 · CA

Neurologic Emergencies Treatment Trials Network: Clinical Coordinating Center

$2,179,483
William G Barsan · University Of Michigan At Ann Arbor · U01 · FY2014 · NS

Clinical and Translational Science Collaborative of Cleveland

$2,179,352
Pamela B Davis · Case Western Reserve University · KL2 · FY2013 · TR

Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer

$2,179,298
Barbara Burtness · Yale University · P50 · FY2024 · DE

ER Network Shaping Mechanisms in the Hereditary Spastic Paraplegias

$2,179,222
Craig Blackstone · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

COG SDMC - Administrative Core

$2,178,569
Todd A Alonzo · Public Health Institute · U10 · FY2021 · CA

PEDIATRIC ONCOLOGY GROUP STATISTICAL OFFICE

$2,178,488
University Of Florida · U10 · FY2000 · CA

Washington University SPORE in Pancreatic Cancer

$2,178,396
David G Denardo · Washington University · P50 · FY2025 · CA

Therapeutic gene editing and multimodal imaging in juvenile macular degenerationÂ

$2,178,277
Stephen H Tsang · Columbia University Health Sciences · R24 · FY2023 · EY

HIV PREVENTION TRIALS UNIT

$2,178,248
Harvard University (Sch Of Public Hlth) · U01 · FY2001 · AI

The Alzheimer's Disease Research Center at the University of California, Irvine

$2,178,033
Frank M Laferla · University Of California-Irvine · P50 · FY2017 · AG

THE ZIMBABWE-SAN FRANCISCO HIV PREVENTION TRIALS UNIT

$2,177,846
Tsungai Chipato · University Of California, San Francisco · U01 · FY2006 · AI

GENE THERAPY FOR BRAIN TUMORS

$2,177,781
Massachusetts General Hospital · P01 · FY2003 · CA

Translational Studies in FLASH Particle Radiotherapy

$2,177,692
Constantinos Koumenis · University Of Pennsylvania · P01 · FY2025 · CA

Engineering T cells to Provide Durable Control of HIV-1 Replication

$2,177,593
James L Riley · University Of Pennsylvania · U19 · FY2019 · AI

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

$2,177,529
James R Cerhan · Mayo Clinic Rochester · U01 · FY2019 · CA

ADMINISTRATIVE AND MEDICAL CORE (AMC)

$2,176,795
David P Salmon · University Of California, San Diego · U01 · FY2009 · AG

Lung Cancer Multiple Reaction Monitoring Project

$2,176,785
William Bocik · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA

ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke

$2,176,709
Patrick D Lyden · Cedars-Sinai Medical Center · U01 · FY2015 · NS

Genetic and Signaling Pathways in Epithelial Thyroid Cancer

$2,176,488
Matthew D Ringel · Ohio State University · P01 · FY2014 · CA

Medical University of South Carolina - Cancer Center Support Grant

$2,176,322
Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2024 · CA

Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE

$2,176,201
Daniel William Cramer · Brigham And Women'S Hospital · P50 · FY2008 · CA

IMMUNITY TO MELANOMA VIA DENDRITIC CELLS

$2,176,103
Baylor Research Institute · P01 · FY2003 · CA

Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)

$2,176,002
Amita Gupta · Johns Hopkins University · UM1 · FY2024 · AI